Following vascular injury, platelet activation and thrombin generation occur in concert in a mutually amplifying scheme to promote the rapid and localized formation of a hemostatic plug. While the important role of platelets in coagulation is now established, interactions between platelets and the fibrinolytic system during clot dissolution have not been elucidated. Studies performed in this laboratory during the previous project period have shown that the fibrinolytic protease plasmin regulates platelet activation in a complex manner that is distinct from the actions of the coagulation protease thrombin. Furthermore, preliminary experiments have shown that plasmin also exerts different actions on vascular endothelial cells (EC).
The aim of this proposal is to investigate in detail the effects of plasmin and the fibrinolytic system on platelets and cultured vascular cells. Hypotheses to explain the complex actions of plasmin on platelets and EC will be pursued by examining the sequence and causal relationships of biochemical events in signal transduction induced by plasmin, and comparing and contrasting these events with those induced by the coagulation protease thrombin as well as other platelet and EC agonists. Studies will specifically focus on the control of phospholipid composition and turnover, protein kinase C activation and arachidonic acid metabolism. Biochemical mechanism of platelet and EC deactivation following stimulation by plasmin and other agonists by negative termination signals will be examined, an area of research in cellular signal- response coupling that has received little attention. Evidence for possibly selective actions of plasmin on the G proteins of adenylate cyclase will be followed with detailed studies of the control of the plasmin effect on platelets and EC by cyclic nucleotides. Preliminary evidence for synergistic inhibitory effects of plasmin and prostacyclin on platelet activation, a potentially important new platelet-EC interaction in controlling hemostasis and clot dissolution, will lead to studies of basic mechanisms of previously unknown synergistic inhibitory signaling pathways in platelets and EC. Studies of the regulation of EC function by plasmin will examine not only blood vessels as targets for actions of the fibrinolytic system but also elucidate basic biochemical mechanisms of signal transduction in vascular cells which are largely unknown. Understanding the modulation of platelet and EC actions and interactions by the fibrinolytic system will have pathophysiologic and pharmacologic importance in clarifying our concepts of thrombosis and hemostasis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL036045-08
Application #
3350579
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1989-09-01
Project End
1993-07-31
Budget Start
1991-08-01
Budget End
1993-07-31
Support Year
8
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Zhang, Daqing; Jiang, Xiaohua; Fang, Pu et al. (2009) Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice. Circulation 120:1893-902
Keswani, Amit N; Peyton, Kelly J; Durante, William et al. (2009) The cyclic GMP modulators YC-1 and zaprinast reduce vessel remodeling through antiproliferative and proapoptotic effects. J Cardiovasc Pharmacol Ther 14:116-24
Tulis, David A (2008) Novel therapies for cyclic GMP control of vascular smooth muscle growth. Am J Ther 15:551-64
Long, Xilin; Schafer, Andrew I (2008) Inhibition of plasminogen activator inhibitor-1 expression in vascular smooth muscle cells by protoporphyrins through a heme oxygenase-independent mechanism. Mol Cell Biochem 312:93-101
Hasan, Rukhsana N; Schafer, Andrew I (2008) Hemin upregulates Egr-1 expression in vascular smooth muscle cells via reactive oxygen species ERK-1/2-Elk-1 and NF-kappaB. Circ Res 102:42-50
Jamaluddin, M D S; Chen, Irene; Yang, Fan et al. (2007) Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene. Blood 110:3648-55
Jiang, Xiaohua; Yang, Fan; Brailoiu, Eugen et al. (2007) Differential regulation of homocysteine transport in vascular endothelial and smooth muscle cells. Arterioscler Thromb Vasc Biol 27:1976-83
Tan, Hongmei; Jiang, Xiaohua; Yang, Fan et al. (2006) Hyperhomocysteinemia inhibits post-injury reendothelialization in mice. Cardiovasc Res 69:253-62
Liao, Dan; Tan, Hongmei; Hui, Rutai et al. (2006) Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance. Circ Res 99:598-606
Tulis, D A; Keswani, A N; Peyton, K J et al. (2005) Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries. Cell Mol Biol (Noisy-le-grand) 51:441-6

Showing the most recent 10 out of 63 publications